Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies?
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
J. Cadranel (Paris, France). Is there a place for ICI in the context of oncogenic addiction?. ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies?

Member's Comments

No comment yet.

Related content which might interest you: What are the main mechanisms of oncogenic addiction? Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine Year: 2019 Understanding nicotine addiction and the health effects of nicotine use Source: Eur Respir Monogr 2021; 90: 18-32 Year: 2021 How to involve more doctors in treatment of tobacco dependence? Source: Annual Congress 2007 - Smoking or health; physician status Year: 2007 Understanding nicotine addiction and the principles of harm reduction Source: International Congress 2018 – Emerging tobacco products and harm reduction: a tobacco solution to a tobacco problem? Year: 2018 Nicotine at the crossroads of smoking addiction and lung cancer & Tumourigenic aspects of nicotine Source: International Congress 2015 – New insights in immunology and molecular pathways of tobacco smoke Year: 2015 Making clinical sense of the explosion in biologics - which drug for which patient and why? Source: International Congress 2019 – PG10 Severe asthma in adults: systematic assessment and biological treatment Year: 2019 Nicotine and cannabis use among teenagers: from prevention to treatment. What works? Source: Virtual Congress 2021 – Orphan childhood disease: nicotine and cannabis addiction Year: 2021 Is there a link between long-term endothelial receptor antagonists therapy and carcinogenesis in PAH: A case series? Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011 What are kids experimenting with? Epidemiology and trends of tobacco use and mental effects of nicotine and cannabis use Source: Virtual Congress 2021 – Orphan childhood disease: nicotine and cannabis addiction Year: 2021 Cannabis use and lung cancer: time to stop overlooking the problem? Source: Eur Respir J, 57 (5) 2004132; 10.1183/13993003.04132-2020 Year: 2021 What we know and what we do not know about cannabis health effects: a concern for lung health? Source: Virtual Congress 2020 – The changing and challenging landscape of the global tobacco epidemic: from vaping to cannabis? Year: 2020 The relation of teenage to maternal smoking behaviour and the possible role of in utero transmission of addiction Source: Eur Respir J 2003; 22: Suppl. 45, 25s Year: 2003 Do users want to be involved in respiratory service development? Source: Eur Respir J 2004; 24: Suppl. 48, 66s Year: 2004 Is there a place for anti-remodelling drugs in asthma which may not display immediate clinical efficacy? Source: Eur Respir J 2004; 24: 1-2 Year: 2004 Why don't patients follow the rules? Understanding the motivation behind behavioural change Source: Annual Congress 2013 –PG8 How to encourage compliance with therapy Year: 2013 Molecular diagnosis for oncogenic addictions Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine Year: 2019